Jubilant Draximage Inc.

Kirkland, QC Doing business as Jubilant Radiopharma Radiopharmaceuticals Division

UEI
M3XTBYTERVN5
CAGE
L02J7
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

FY2025 rankings

Its parent company, Jubilant Life Sciences Limited, ranks #92 in NAICS 325412

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
16751 A. Transcanadienne, Kirkland, QC H9H 2J4, Canada
Founded
2019
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $522,129
FY2025 $512,048
FY2024 $766,107
FY2023 $646,503

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $522,129

Contract awards

Award Agency Obligated Awarded
Radioactive isotopes 36C25026N0010 Veterans Integrated Service Network 10 (VHA) $600,000
Radioactive isotopes 36C25025N0018 Veterans Integrated Service Network 10 (VHA) -$45,796
Radio pharmaceuticals 36C25224N0234 Veterans Integrated Service Network 12 (VHA) $172,609
Radioactive isotopes 36C25024N0008 Veterans Integrated Service Network 10 (VHA) $521,097
Radio pharmaceuticals 36C25223N0292 Veterans Integrated Service Network 12 (VHA) $239,104

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Jubilant Draximage Inc., doing business as Jubilant Radiopharma, is a Canadian-based pharmaceutical company specializing in nuclear medicine products and services. Registered in SAM.gov since 2012, the company is a for-profit organization and manufacturer of goods that primarily provides radiopharmaceutical products to federal agencies. The company operates from its facility in Kirkland, Quebec, and focuses on developing and supplying critical nuclear medicine diagnostic and treatment supplies.

The company has been awarded multiple federal contracts exclusively with the Department of Veterans Affairs (VA) through various Veterans Integrated Service Networks (VISNs), including VISN 4, VISN 5, VISN 10, VISN 12, and VISN 22. These contracts consistently involve the provision of radioactive isotopes, radiopharmaceutical products, and specialized medical supplies such as NETSPOT (gallium 68 dotatate), rubidium-82 generators, and other nuclear medicine diagnostic products. All contracts have been awarded through full and open competition with no specific set-aside designations, indicating Jubilant Radiopharma's competitive position in supplying these critical medical supplies. The contract values have ranged from approximately $78,300 to $1,059,449.87, with delivery orders primarily supporting nuclear medicine services at various VA medical centers across different geographic regions.

Jubilant Radiopharma holds two significant Indefinite Delivery Contracts (IDCs) with the VA. The first IDC, awarded by VISN 12, has a ceiling value of $866,632.41 and expires on January 31, 2025, focused on radio pharmaceuticals. The second IDC, awarded by VISN 10, has a substantially larger ceiling value of $3,500,000.00 and expires on September 30, 2026, specifically for radioactive isotopes. Both IDCs are single-award contracts that have generated multiple firm-fixed price delivery orders. These IDCs demonstrate the company's strategic importance in supplying nuclear medicine supplies to VA medical centers, with contract performance locations spanning facilities in states such as Florida, Georgia, Pennsylvania, and California.

Quick answers

Is Jubilant Draximage Inc. registered in SAM.gov?

Yes. Jubilant Draximage Inc.'s SAM.gov registration is active through December 17, 2026.

How much has Jubilant Draximage Inc. received in federal contracts?

Federal contracts obligated $512,048 to Jubilant Draximage Inc. in fiscal year 2025 and $2,446,787 in fiscal years 2023 through 2027.

How does Jubilant Draximage Inc. rank among federal contractors?

Jubilant Draximage Inc.'s parent company, Jubilant Life Sciences Limited, ranked #92 in NAICS 325412 in FY2025.

What is Jubilant Draximage Inc.'s most recent federal award?

Jubilant Draximage Inc.'s most recent federal contract award is Radioactive isotopes (36C25026N0010), from Veterans Integrated Service Network 10 (VHA), on October 1, 2025.

On GovTribe

See Jubilant Draximage Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors